TITLE

Current trends of HIV recombination worldwide

AUTHOR(S)
Lau, Katherine A.; Wong, Justin J. L.
PUB. DATE
March 2013
SOURCE
Infectious Disease Reports;2013, Vol. 5 Issue 1s, p15
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
One of the major characteristics of HIV-1 is its high genetic variability and extensive heterogeneity. This characteristic is due to its molecular traits, which in turn allows it to vary, recombine, and diversify at a high frequency. As such, it generates complex molecular forms, termed recombinants, which evade the human immune system and so survive. There is no sequence constraint to the recombination pattern as it appears to occur at inter-group (between groups M and O), as well as interand intra-subtype within group M. Rapid emergence and active global transmission of HIV-1 recombinants, known as circulating recombinant forms (CRFs) and unique recombinant forms (URFs), requires urgent attention. To date, 55 CRFs have been reported around the world. The first CRF01_AE originated from Central Africa but spread widely in Asia. The most recent CRF; CRF55_01B is a recombinant form of CRF01_AE and subtype B, although its origin is yet to be publicly disclosed. HIV-1 recombination is an ongoing event and plays an indispensable role in HIV epidemics in different regions. Africa, Asia and South America are identified as recombination hot-spots. They are affected by continual emergence and cocirculation of newly emerging CRFs and URFs, which are now responsible for almost 20% of HIV-1 infections worldwide. Better understanding of recombinants is necessary to determine their biological and molecular attributes.
ACCESSION #
93580537

 

Related Articles

  • Production and expression of recombinant anti-V3 scFvs from HIV-1 clade C infected Indian patient. Kumar, Rajesh; Andrabi, Raiees; Tiwari, Ashutosh; Prakash, Somi Sankaran; Wig, Naveet; Dutta, Durgashree; Sankhyan, Anurag; Khan, Lubina; Sinha, Subrata; Luthra, Kalpana // Retrovirology;2012 Supplement 1, Vol. 9 Issue Supplment 1, p1 

    An abstract of the article "Production and expression of recombinant anti-V3 scFvs from HIV-1 clade C infected Indian patient," by Rajesh Kumar, Raiees Andrabi, Ashutosh Tiwari, Somi Sankaran Prakash, Naveet Wig, Durgashree Dutta, Anurag Sankhyan, Lubina Khan, and Subrata Sinha is presented.

  • Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Pope, Melissa; Haase, Ashley T // Nature Medicine;Jul2003, Vol. 9 Issue 7, p847 

    By the acute stage of HIV-1 infection, the immune system already faces daunting challenges. Research on mucosal barriers and the events immediately after heterosexual transmission that precede this acute stage could facilitate the development of effective microbicides and vaccines.

  • Fatal Immune Restoration Disease in Human Immunodeficiency Virus Type 1--Infected Patients with Progressive Multifocal Leukoencephalopathy: Impact of Antiretroviral Therapy--Associated Immune Reconstitution. Safdar, Amar; Rubocki, Ronald J.; Horvath, Joseph A.; Narayan, Kailash K.; Waldron, Robert L. // Clinical Infectious Diseases;11/15/2002, Vol. 35 Issue 10, p1250 

    Immune reconstitution resulting from use of highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 1 (HIV-1) has been associated with a significant decrease in infectious morbidity and with improved survival. Occasionally, patients with quiescent disease...

  • HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies. Kiwelu, Ireen E.; Novitsky, Vladimir; Margolin, Lauren; Baca, Jeannie; Manongi, Rachel; Sam, Noel; Shao, John; McLane, Mary F.; Kapiga, Saidi H.; Essex, M. // PLoS ONE;Oct2012, Vol. 7 Issue 10, Special section p1 

    This study analyzed the distribution and prevalence of HIV-1 subtypes, multiplicity of HIV-1 infection, and frequency of inter-subtype recombination among HIV-1-infected female bar and hotel workers in Moshi, Kilimanjaro Region, Tanzania, from 2004 to 2007. The HIV-1 viral sequences spanning the...

  • Generation of a Recombinant Gag Virus-Like-Particle Panel for the Evaluation of p24 Antigen Detection by Diagnostic HIV Tests. Vetter, Beatrice N.; Orlowski, Vanessa; Fransen, Katrien; Niederhauser, Christoph; Aubert, Vincent; Brandenberger, Marcel; Ciardo, Diana; Dollenmaier, Günter; Klimkait, Thomas; Regenass, Stephan; Schmid, Patrick; Schottstedt, Volkmar; Suter-Riniker, Franziska; Yerly, Sabine; Shah, Cyril; Böni, Jürg; Schüpbach, Jörg // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    Background: Detection of HIV-1 p24 antigen permits early identification of primary HIV infection and timely intervention to limit further spread of the infection. Principally, HIV screening should equally detect all viral variants, but reagents for a standardised test evaluation are limited....

  • HIV tropism and CD4+ T-cell depletion. Hellerstein, Marc // Nature Medicine;Jun2002, Vol. 8 Issue 6, p537 

    Discusses the critical role of immune activation in HIV-1 pathogenesis. Analysis of conclusions of the study conducted by Gossman et al.; Destruction of CD4[sup+] T-cells by HIV-1; Emphasis on the study of phenotype of HIV-1 strains that are present in infected humans; Reasons for understanding...

  • Human Immunodeficiency Virus Pathogenesis and Prospects for Immune Control in Patients with Established Infection. Mayer, Kenneth H.; Cohen, Daniel E.; Walker, Bruce D. // Clinical Infectious Diseases;6/15/2001, Vol. 32 Issue 12, p1756 

    Focuses on the clinical implications of advances in understanding HIV-1 pathogenesis, with particular emphasis on the role of immune responses in controlling viremia. Natural history of acute HIV infection; Clinical manifestations of acute HIV-1 infection; Viral and host factors that influence...

  • Recombinant Human Polyclonal Antibodies: A New Class of Therapeutic Antibodies Against Viral Infections. Bregenholt, S�ren; Jensen, Allan; Lantto, Johan; Hyldig, Sara; Haurum, John S. // Current Pharmaceutical Design;Jun2006, Vol. 12 Issue 16, p2007 

    The mammalian immune system eliminates pathogens by generating a specific antibody response. Polyclonality is a key feature of this immune response: the immune system produces antibodies which bind to different structures on a given pathogen thereby increasing the likelihood of its elimination....

  • CREATION OF A HIGH-YIELDING RECOMBINANT MAIZE HYBRID FOR THE PRODUCTION OF A MICROBICIDE TO PREVENT HIV-1 TRANSMISSION. Barros, Eugenia; Nelson, Sydney W. // South African Journal of Science;May/Jun2010, Vol. 106 Issue 5/6, p1 

    The aim of this study was to use conventional breeding to increase the production in maize of the human monoclonal antibody 2G12, known to have potential therapeutic properties in the prevention of HIV-1 transmission. The recombinant antibody, together with a fluorescent marker, was introduced...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics